New perspectives in diabetic neuropathy

[1]  T. Gardner,et al.  The effect of surgical weight loss on diabetes complications in individuals with class II/III obesity , 2023, Diabetologia.

[2]  Marin L. Gantner,et al.  Insulin-regulated serine and lipid metabolism drive peripheral neuropathy , 2023, Nature.

[3]  K. Sango,et al.  RAGE activation in macrophages and development of experimental diabetic polyneuropathy , 2022, JCI insight.

[4]  S. Dib-Hajj,et al.  Maximizing treatment efficacy through patient stratification in neuropathic pain trials , 2022, Nature Reviews Neurology.

[5]  Olga Komargodski,et al.  Painful Diabetic Neuropathy - Spinal Cord Stimulation, Peripheral Nerve Stimulation, Transcutaneous Electrical Nerve Stimulation, and Scrambler Therapy: A Narrative Review. , 2022, Pain physician.

[6]  M. Davies,et al.  Type 2 diabetes , 2022, The Lancet.

[7]  E. Feldman,et al.  Towards prevention of diabetic peripheral neuropathy: clinical presentation, pathogenesis, and new treatments , 2022, The Lancet Neurology.

[8]  J. Vollert,et al.  Continuum of sensory profiles in diabetes mellitus patients with and without neuropathy and pain , 2022, European journal of pain.

[9]  Yu-Pu Liu,et al.  Schwann cells-derived exosomal miR-21 participates in high glucose regulation of neurite outgrowth , 2022, iScience.

[10]  J. Hur,et al.  A High-Fat Diet Disrupts Nerve Lipids and Mitochondrial Function in Murine Models of Neuropathy , 2022, Frontiers in Physiology.

[11]  G. Michailidis,et al.  Serum lipidomic determinants of human diabetic neuropathy in type 2 diabetes , 2022, Annals of clinical and translational neurology.

[12]  Venkatesh Natarajan,et al.  Effect of various exercise protocols on neuropathic pain in individuals with type 2 diabetes with peripheral neuropathy: A systematic review and meta-analysis. , 2022, Diabetes & metabolic syndrome.

[13]  H. Smeets,et al.  Peripheral Ion Channel Gene Screening in Painful- and Painless-Diabetic Neuropathy , 2022, International journal of molecular sciences.

[14]  G. Tesco,et al.  Pathophysiology of neurodegenerative diseases: An interplay among axonal transport failure, oxidative stress, and inflammation? , 2022, Seminars in immunology.

[15]  Yi-ze Li,et al.  MicroRNA‐7a‐5p ameliorates diabetic peripheral neuropathy by regulating VDAC1/JNK/c‐JUN pathway , 2022, Diabetic medicine : a journal of the British Diabetic Association.

[16]  Xiaosheng Yang,et al.  The Development of Mechanical Allodynia in Diabetic Rats Revealed by Single-Cell RNA-Seq , 2022, Frontiers in Molecular Neuroscience.

[17]  B. Beirowski.  Emerging evidence for compromised axonal bioenergetics and axoglial metabolic coupling as drivers of neurodegeneration , 2022, Neurobiology of Disease.

[18]  B. Beirowski,et al.  Of axons struggling making ends meet: Linking axonal bioenergetic failure to programmed axon degeneration. , 2022, Biochimica et biophysica acta. Bioenergetics.

[19]  M. Roden,et al.  High-intensity interval training for 12 weeks improves cardiovascular autonomic function but not somatosensory nerve function and structure in overweight men with type 2 diabetes , 2022, Diabetologia.

[20]  S. Sindrup,et al.  The characteristics of pain and dysesthesia in patients with diabetic polyneuropathy , 2022, PloS one.

[21]  B. Zinman,et al.  The impact of canagliflozin on the risk of neuropathy events: a post-hoc exploratory analysis of the CREDENCE trial. , 2022, Diabetes & metabolism.

[22]  N. Finnerup,et al.  Effects of progressive resistance training in individuals with type 2 diabetic polyneuropathy: a randomised assessor-blinded controlled trial , 2022, Diabetologia.

[23]  A. Munshi,et al.  Role of miRNAs in diabetic neuropathy: mechanisms and possible interventions , 2022, Molecular Neurobiology.

[24]  G. Gronseth,et al.  Oral and Topical Treatment of Painful Diabetic Polyneuropathy: Practice Guideline Update Summary , 2021, Neurology.

[25]  Andreas C. Themistocleous,et al.  Classification of painful or painless diabetic peripheral neuropathy and identification of the most powerful predictors using machine learning models in large cross-sectional cohorts , 2021, BMC Medical Informatics and Decision Making.

[26]  M. Iadarola,et al.  Transcriptomic analysis of human sensory neurons in painful diabetic neuropathy reveals inflammation and neuronal loss , 2021, Scientific Reports.

[27]  E. Feldman,et al.  Systems Biology to Address Unmet Medical Needs in Neurological Disorders. , 2022, Methods in molecular biology.

[28]  S. Eid,et al.  Nox, Nox, Are You There? The Role of NADPH Oxidases in the Peripheral Nervous System. , 2021, Antioxidants & redox signaling.

[29]  B. Duncan,et al.  IDF diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045 , 2021, Diabetes Research and Clinical Practice.

[30]  J. Hur,et al.  Plasma Metabolomics and Lipidomics Differentiate Obese Individuals by Peripheral Neuropathy Status. , 2021, The Journal of clinical endocrinology and metabolism.

[31]  J. Nyengaard,et al.  Analysis of Macrophages and Peptidergic Fibers in the Skin of Patients With Painful Diabetic Polyneuropathy , 2021, Neurology: Neuroimmunology & Neuroinflammation.

[32]  M. Banerjee,et al.  Dietary weight loss in people with severe obesity stabilizes neuropathy and improves symptomatology , 2021, Obesity.

[33]  Yong Chen,et al.  Sitagliptin Reduces Endothelial Dysfunction and Apoptosis Induced by High-Fat Diet and Palmitate in Thoracic Aortas and Endothelial Cells via ROS-ER Stress-CHOP Pathway , 2021, Frontiers in Pharmacology.

[34]  D. Wright,et al.  A ketogenic diet reduces mechanical allodynia and improves epidermal innervation in diabetic mice. , 2021, Pain.

[35]  C. Arias,et al.  Palmitic acid induces insulin resistance by a mechanism associated with energy metabolism and calcium entry in neuronal cells , 2021, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[36]  J. Hur,et al.  Microbial and genetic-based framework identifies drug targets in inflammatory bowel disease , 2021, Theranostics.

[37]  S. Yagihashi,et al.  Inhibitory effects of xanthine oxidase inhibitor, topiroxostat, on development of neuropathy in db/db mice , 2021, Neurobiology of Disease.

[38]  M. Jørgensen,et al.  Plasma lipid metabolites associate with diabetic polyneuropathy in a cohort with type 2 diabetes , 2021, Annals of clinical and translational neurology.

[39]  Daying Zhang,et al.  Oxidative stress induced by NOX2 contributes to neuropathic pain via plasma membrane translocation of PKCε in rat dorsal root ganglion neurons , 2021, Journal of Neuroinflammation.

[40]  J. Savas,et al.  Mitochondrial calcium uniporter deletion prevents painful diabetic neuropathy by restoring mitochondrial morphology and dynamics , 2021, Pain.

[41]  David L. Bennett,et al.  Studying human nociceptors: from fundamentals to clinic , 2021, Brain : a journal of neurology.

[42]  D. Bogićević,et al.  Genetic and Epigenomic Modifiers of Diabetic Neuropathy , 2021, International journal of molecular sciences.

[43]  H. V. Jagadish,et al.  Gene expression profiles of diabetic kidney disease and neuropathy in eNOS knockout mice: Predictors of pathology and RAS blockade effects , 2021, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[44]  D. Caraway,et al.  Effect of High-frequency (10-kHz) Spinal Cord Stimulation in Patients With Painful Diabetic Neuropathy , 2021, JAMA neurology.

[45]  Kenneth J. Smith,et al.  High Dietary Fat Consumption Impairs Axonal Mitochondrial Function In Vivo , 2021, The Journal of Neuroscience.

[46]  I. Wilkinson,et al.  Somatosensory network functional connectivity differentiates clinical pain phenotypes in diabetic neuropathy , 2021, Diabetologia.

[47]  M. Bhasin,et al.  Single cell transcriptomic landscape of diabetic foot ulcers , 2021, Nature Communications.

[48]  Andreas C. Themistocleous,et al.  Painful and non-painful diabetic neuropathy, diagnostic challenges and implications for future management. , 2021, Brain : a journal of neurology.

[49]  Wei Song,et al.  Quercetin Attenuates Diabetic Peripheral Neuropathy by Correcting Mitochondrial Abnormality via Activation of AMPK/PGC-1α Pathway in vivo and in vitro , 2021, Frontiers in Neuroscience.

[50]  P. Rinwa,et al.  Demise of nociceptive Schwann cells causes nerve retraction and pain hyperalgesia , 2021, Pain.

[51]  S. Eid,et al.  Differential effects of minocycline on microvascular complications in murine models of type 1 and type 2 diabetes , 2020, Journal of translational science.

[52]  H. Mizukami,et al.  Collateral Glucose-Utlizing Pathwaya in Diabetic Polyneuropathy , 2020, International journal of molecular sciences.

[53]  M. Roden,et al.  Interaction between magnesium and methylglyoxal in diabetic polyneuropathy and neuronal models , 2020, Molecular metabolism.

[54]  S. Waxman,et al.  Status of peripheral sodium channel blockers for non-addictive pain treatment , 2020, Nature Reviews Neurology.

[55]  R. Donn,et al.  Improvements in Diabetic Neuropathy and Nephropathy After Bariatric Surgery: a Prospective Cohort Study , 2020, Obesity Surgery.

[56]  Mohamed Kazamel,et al.  Metabolic syndrome and peripheral neuropathy , 2020, Muscle & nerve.

[57]  S. Eid,et al.  Differential Effects of Empagliflozin on Microvascular Complications in Murine Models of Type 1 and Type 2 Diabetes , 2020, Biology.

[58]  H. Sørensen,et al.  Statin Therapy and Risk of Polyneuropathy in Type 2 Diabetes: A Danish Cohort Study , 2020, Diabetes Care.

[59]  S. Madduri,et al.  Schwann Cell-Like Cells: Origin and Usability for Repair and Regeneration of the Peripheral and Central Nervous System , 2020, Cells.

[60]  B. Beirowski,et al.  Publisher Correction: A glycolytic shift in Schwann cells supports injured axons , 2020, Nature Neuroscience.

[61]  S. Eid,et al.  Genome-wide profiling of DNA methylation and gene expression identifies candidate genes for human diabetic neuropathy , 2020, Clinical Epigenetics.

[62]  Radhika S. Khetani,et al.  Integrated Skin Transcriptomics and Serum Multiplex Assays Reveal Novel Mechanisms of Wound Healing in Diabetic Foot Ulcers , 2020, Diabetes.

[63]  S. Twigg,et al.  Metabolic syndrome in type 1 diabetes and its association with diabetes complications , 2020, Diabetic medicine : a journal of the British Diabetic Association.

[64]  A. Dejean,et al.  SUMOylation of Enzymes and Ion Channels in Sensory Neurons Protects against Metabolic Dysfunction, Neuropathy, and Sensory Loss in Diabetes , 2020, Neuron.

[65]  E. Feldman,et al.  Diabetic neuropathy in children and youth: New and emerging risk factors , 2020, Pediatric diabetes.

[66]  C. Svensson,et al.  Disrupted function of lactate transporter MCT1, but not MCT4, in Schwann cells affects the maintenance of motor end‐plate innervation , 2020, Glia.

[67]  Weiqi Wang,et al.  DW14006 as a Direct AMPKα Activator Ameliorates Diabetic Peripheral Neuropathy in Mice , 2020, Diabetes.

[68]  W. Mess,et al.  Cardiometabolic risk factors as determinants of peripheral nerve function: the Maastricht Study , 2020, Diabetologia.

[69]  Alejandro F Frangi,et al.  The UK Biobank imaging enhancement of 100,000 participants: rationale, data collection, management and future directions , 2020, Nature Communications.

[70]  J. Milbrandt,et al.  Peripheral nerve resident macrophages share tissue-specific programming and features of activated microglia , 2020, Nature Communications.

[71]  P. Scheltens,et al.  Understanding multifactorial brain changes in type 2 diabetes: a biomarker perspective , 2020, The Lancet Neurology.

[72]  Y. Tao,et al.  Caveolin-1 in spinal cord modulates type-2 diabetic neuropathic pain through the Rac1/NOX2/NR2B signaling pathway. , 2020, American journal of translational research.

[73]  Anton J. Enright,et al.  Schwann cell reprogramming into repair cells increases miRNA-21 expression in exosomes promoting axonal growth , 2020, Journal of Cell Science.

[74]  Alexander E. Lopez,et al.  Discovery of 318 new risk loci for type 2 diabetes and related vascular outcomes among 1.4 million participants in a multi-ethnic meta-analysis , 2020, Nature Genetics.

[75]  G. Lenaers,et al.  Physiology of PNS axons relies on glycolic metabolism in myelinating Schwann cells , 2020, bioRxiv.

[76]  H. Sørensen,et al.  Metabolic Factors, Lifestyle Habits, and Possible Polyneuropathy in Early Type 2 Diabetes: A Nationwide Study of 5,249 Patients in the Danish Centre for Strategic Research in Type 2 Diabetes (DD2) Cohort , 2020, Diabetes Care.

[77]  Y. Poitelon,et al.  Myelin Fat Facts: An Overview of Lipids and Fatty Acid Metabolism , 2020, Cells.

[78]  Y. Liu,et al.  Reducing monocarboxylate transporter MCT1 worsens experimental diabetic peripheral neuropathy , 2020, Experimental Neurology.

[79]  M. Banerjee,et al.  The Prevalence and Determinants of Cognitive Deficits and Traditional Diabetic Complications in the Severely Obese , 2020, Diabetes Care.

[80]  M. Chopp,et al.  Exosomes Derived From Schwann Cells Ameliorate Peripheral Neuropathy in Type 2 Diabetic Mice , 2020, Diabetes.

[81]  J. Rothstein,et al.  Monocarboxylate transporter 1 in Schwann cells contributes to maintenance of sensory nerve myelination during aging , 2020, Glia.

[82]  Batoul Dia,et al.  Targeting the NADPH Oxidase-4 and Liver X Receptor Pathway Preserves Schwann Cell Integrity in Diabetic Mice , 2019, Diabetes.

[83]  S. Tenzer,et al.  Oligodendrocytes support axonal transport and maintenance via exosome secretion , 2019, bioRxiv.

[84]  J. Hur,et al.  Toll-like receptors and inflammation in metabolic neuropathy; a role in early versus late disease? , 2019, Experimental Neurology.

[85]  M. Jørgensen,et al.  Prospective Study of Neuropathic Symptoms Preceding Clinically Diagnosed Diabetic Polyneuropathy: ADDITION-Denmark , 2019, Diabetes Care.

[86]  J. Shaw,et al.  Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the International Diabetes Federation Diabetes Atlas, 9th edition. , 2019, Diabetes research and clinical practice.

[87]  Yi Luan,et al.  Sarm1 Gene Deficiency Attenuates Diabetic Peripheral Neuropathy in Mice , 2019, Diabetes.

[88]  Jiang Peng,et al.  Role of macrophages in peripheral nerve injury and repair , 2019, Neural regeneration research.

[89]  Y. Sadovsky,et al.  The biology of extracellular vesicles: The known unknowns , 2019, PLoS biology.

[90]  B. Namer,et al.  Methylglyoxal causes pain and hyperalgesia in human through C-fiber activation. , 2019, Pain.

[91]  E. Feldman,et al.  Diabetic neuropathy , 2019, Nature Reviews Disease Primers.

[92]  S. Eid,et al.  Genome-wide DNA methylation profiling of human diabetic peripheral neuropathy in subjects with type 2 diabetes mellitus , 2019, Epigenetics.

[93]  J. Russell,et al.  Physical activity and dietary interventions in diabetic neuropathy: a systematic review , 2019, Clinical Autonomic Research.

[94]  E. Feldman,et al.  The Divergent Roles of Dietary Saturated and Monounsaturated Fatty Acids on Nerve Function in Murine Models of Obesity , 2019, The Journal of Neuroscience.

[95]  J. B. Groener,et al.  Association of Serum Cholesterol Levels With Peripheral Nerve Damage in Patients With Type 2 Diabetes , 2019, JAMA network open.

[96]  S. Dib-Hajj,et al.  A gain-of-function sodium channel β2-subunit mutation in painful diabetic neuropathy , 2019, Molecular pain.

[97]  E. Feldman,et al.  Mitochondrial uncoupling has no effect on microvascular complications in type 2 diabetes , 2019, Scientific Reports.

[98]  I. Wilkinson,et al.  Structural and Functional Abnormalities of the Primary Somatosensory Cortex in Diabetic Peripheral Neuropathy: A Multimodal MRI Study , 2019, Diabetes.

[99]  S. Matsuzaki,et al.  Inflammatory Macrophages in the Sciatic Nerves Facilitate Neuropathic Pain Associated with Type 2 Diabetes Mellitus , 2019, The Journal of Pharmacology and Experimental Therapeutics.

[100]  S. Eid,et al.  Integrated lipidomic and transcriptomic analyses identify altered nerve triglycerides in mouse models of prediabetes and type 2 diabetes , 2019, Disease Models & Mechanisms.

[101]  N. Calcutt,et al.  Insulin-like growth factor-1 activates AMPK to augment mitochondrial function and correct neuronal metabolism in sensory neurons in type 1 diabetes , 2018, Molecular metabolism.

[102]  K. Chandrasekaran,et al.  Role of mitochondria in diabetic peripheral neuropathy: Influencing the NAD+-dependent SIRT1-PGC-1α-TFAM pathway. , 2019, International review of neurobiology.

[103]  E. Feldman,et al.  Disorders of mitochondrial dynamics in peripheral neuropathy: Clues from hereditary neuropathy and diabetes. , 2019, International review of neurobiology.

[104]  W. Rathmann,et al.  General and Abdominal Obesity and Incident Distal Sensorimotor Polyneuropathy: Insights Into Inflammatory Biomarkers as Potential Mediators in the KORA F4/FF4 Cohort , 2018, Diabetes Care.

[105]  Brett A. McGregor,et al.  Conserved Transcriptional Signatures in Human and Murine Diabetic Peripheral Neuropathy , 2018, Scientific Reports.

[106]  E. Feldman,et al.  Chain length of saturated fatty acids regulates mitochondrial trafficking and function in sensory neurons , 2018, Journal of Lipid Research.

[107]  A. Bookout,et al.  Liver X Receptors Protect Dorsal Root Ganglia from Obesity-Induced Endoplasmic Reticulum Stress and Mechanical Allodynia , 2018, Cell reports.

[108]  G. Shulman,et al.  Mechanisms of Insulin Action and Insulin Resistance. , 2018, Physiological reviews.

[109]  C. Slawson,et al.  Real Talk: The Inter-play Between the mTOR, AMPK, and Hexosamine Biosynthetic Pathways in Cell Signaling , 2018, Front. Endocrinol..

[110]  David L. Bennett,et al.  The Novel Activity of Carbamazepine as an Activation Modulator Extends from NaV1.7 Mutations to the NaV1.8-S242T Mutant Channel from a Patient with Painful Diabetic Neuropathy , 2018, Molecular Pharmacology.

[111]  G. Pekkurnaz,et al.  Mechanisms Orchestrating Mitochondrial Dynamics for Energy Homeostasis. , 2018, Journal of molecular biology.

[112]  Jatin Kalita,et al.  Molecular mechanism of diabetic neuropathy and its pharmacotherapeutic targets , 2018, European journal of pharmacology.

[113]  D. Maahs,et al.  Obesity in Type 1 Diabetes: Pathophysiology, Clinical Impact, and Mechanisms. , 2018, Endocrine reviews.

[114]  D. Bates,et al.  Sensory neuronal sensitisation occurs through HMGB-1–RAGE and TRPV1 in high-glucose conditions , 2018, Journal of Cell Science.

[115]  Blair H. Smith,et al.  Neuropathic pain clinical trials: factors associated with decreases in estimated drug efficacy , 2018, Pain.

[116]  Yanzhuo Zhang,et al.  Inhibition of miR-25 aggravates diabetic peripheral neuropathy , 2018, Neuroreport.

[117]  C. Parada,et al.  Transcriptome analysis of dorsal root ganglia's diabetic neuropathy reveals mechanisms involved in pain and regeneration , 2018, Life sciences.

[118]  J. Hur,et al.  Transcriptional networks of progressive diabetic peripheral neuropathy in the db/db mouse model of type 2 diabetes: An inflammatory story , 2018, Experimental Neurology.

[119]  M. Chopp,et al.  Exosomes derived from high‐glucose‐stimulated Schwann cells promote development of diabetic peripheral neuropathy , 2018, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[120]  R. Landgraf,et al.  Painful and painless neuropathies are distinct and largely undiagnosed entities in subjects participating in an educational initiative (PROTECT study). , 2018, Diabetes research and clinical practice.

[121]  D. Zochodne,et al.  Diabetic neuropathy and the sensory neuron: New aspects of pathogenesis and their treatment implications , 2018, Journal of diabetes investigation.

[122]  E. Davidson,et al.  Effect of dietary oils on peripheral neuropathy-related endpoints in dietary obese rats , 2018, Diabetes, metabolic syndrome and obesity : targets and therapy.

[123]  T. Lauritzen,et al.  Risk Factors for Incident Diabetic Polyneuropathy in a Cohort With Screen-Detected Type 2 Diabetes Followed for 13 Years: ADDITION-Denmark , 2018, Diabetes Care.

[124]  M. Banerjee,et al.  Diabetes and obesity are the main metabolic drivers of peripheral neuropathy , 2018, Annals of clinical and translational neurology.

[125]  Liping Xu,et al.  IRE1α siRNA relieves endoplasmic reticulum stress-induced apoptosis and alleviates diabetic peripheral neuropathy in vivo and in vitro , 2018, Scientific Reports.

[126]  R. Tanzi,et al.  Cytokine-mediated inflammation mediates painful neuropathy from metabolic syndrome , 2018, PloS one.

[127]  Andreas C. Themistocleous,et al.  A brain-based pain facilitation mechanism contributes to painful diabetic polyneuropathy , 2018, Brain : a journal of neurology.

[128]  E. Feldman,et al.  Dyslipidemia impairs mitochondrial trafficking and function in sensory neurons , 2018, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[129]  Andreas C. Themistocleous,et al.  Rare NaV1.7 variants associated with painful diabetic peripheral neuropathy , 2017, Pain.

[130]  L. Dimeglio,et al.  Type 1 Diabetes , 2019, Epidemiology of Diabetes.

[131]  H. V. Jagadish,et al.  Shared and distinct lipid-lipid interactions in plasma and affected tissues in a diabetic mouse model[S] , 2017, Journal of Lipid Research.

[132]  E. Feldman,et al.  Dual CCR2/CCR5 antagonist treatment attenuates adipose inflammation, but not microvascular complications in ob/ob mice , 2017, Diabetes, obesity & metabolism.

[133]  P. McNaughton,et al.  Hyperpolarization-activated cyclic nucleotide–gated 2 (HCN2) ion channels drive pain in mouse models of diabetic neuropathy , 2017, Science Translational Medicine.

[134]  A. Höke,et al.  Deletion of Sarm1 gene is neuroprotective in two models of peripheral neuropathy , 2017, Journal of the peripheral nervous system : JPNS.

[135]  S. Saydah,et al.  Prevalence of and Risk Factors for Diabetic Peripheral Neuropathy in Youth With Type 1 and Type 2 Diabetes: SEARCH for Diabetes in Youth Study , 2017, Diabetes Care.

[136]  T. Wolever,et al.  Effect of omega-3 supplementation on neuropathy in type 1 diabetes , 2017, Neurology.

[137]  O. Franco,et al.  High body mass and kidney dysfunction relate to worse nerve function, even in adults without neuropathy , 2017, Journal of the peripheral nervous system : JPNS.

[138]  E. Feldman,et al.  Dietary reversal of neuropathy in a murine model of prediabetes and metabolic syndrome , 2017, Disease Models & Mechanisms.

[139]  K. Nave,et al.  New Horizons in Diabetic Neuropathy: Mechanisms, Bioenergetics, and Pain , 2017, Neuron.

[140]  D. Wright,et al.  A Role for Insulin in Diabetic Neuropathy , 2016, Front. Neurosci..

[141]  R. Freeman,et al.  Diabetic Neuropathy: A Position Statement by the American Diabetes Association , 2016, Diabetes Care.

[142]  Kumar Sharma,et al.  Tissue-specific metabolic reprogramming drives nutrient flux in diabetic complications. , 2016, JCI insight.

[143]  S. Löwel,et al.  Oligodendroglial NMDA Receptors Regulate Glucose Import and Axonal Energy Metabolism , 2016, Neuron.

[144]  M. Chattopadhyay,et al.  Viral vector mediated continuous expression of interleukin-10 in DRG alleviates pain in type 1 diabetic animals , 2016, Molecular and Cellular Neuroscience.

[145]  H. V. Jagadish,et al.  Transcriptional networks of murine diabetic peripheral neuropathy and nephropathy: common and distinct gene expression patterns , 2016, Diabetologia.

[146]  Blair H. Smith,et al.  Neuropathic pain: an updated grading system for research and clinical practice , 2016, Pain.

[147]  Jonathan G. Lees,et al.  The Pain in Neuropathy Study (PiNS): a cross-sectional observational study determining the somatosensory phenotype of painful and painless diabetic neuropathy , 2016, Pain.

[148]  J. Hur,et al.  Gender-specific differences in diabetic neuropathy in BTBR ob/ob mice. , 2016, Journal of diabetes and its complications.

[149]  P. Fernyhough.  Mitochondrial Dysfunction in Diabetic Neuropathy: a Series of Unfortunate Metabolic Events , 2015, Current Diabetes Reports.

[150]  M. Kretzler,et al.  The Metabolic Syndrome and Microvascular Complications in a Murine Model of Type 2 Diabetes , 2015, Diabetes.

[151]  Blair H. Smith,et al.  Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis , 2015, The Lancet Neurology.

[152]  P. Magistretti,et al.  Deficiency in monocarboxylate transporter 1 (MCT1) in mice delays regeneration of peripheral nerves following sciatic nerve crush , 2015, Experimental Neurology.

[153]  L. Ruan,et al.  Altered microRNAs expression profiling in mice with diabetic neuropathic pain. , 2015, Biochemical and biophysical research communications.

[154]  M. Yorek.  Vascular Impairment of Epineurial Arterioles of the Sciatic Nerve: Implications for Diabetic Peripheral Neuropathy. , 2015, The review of diabetic studies : RDS.

[155]  H. Luhmann,et al.  Multifaceted effects of oligodendroglial exosomes on neurons: impact on neuronal firing rate, signal transduction and gene regulation , 2014, Philosophical Transactions of the Royal Society B: Biological Sciences.

[156]  J. Milbrandt,et al.  Metabolic regulator LKB1 is crucial for Schwann cell–mediated axon maintenance , 2014, Nature Neuroscience.

[157]  E. Feldman,et al.  Long-chain acyl coenzyme A synthetase 1 overexpression in primary cultured Schwann cells prevents long chain fatty acid-induced oxidative stress and mitochondrial dysfunction. , 2014, Antioxidants & redox signaling.

[158]  Gulcin Pekkurnaz,et al.  Glucose Regulates Mitochondrial Motility via Milton Modification by O-GlcNAc Transferase , 2014, Cell.

[159]  Bin Zhang,et al.  Curcumin ameliorated diabetic neuropathy partially by inhibition of NADPH oxidase mediating oxidative stress in the spinal cord , 2014, Neuroscience Letters.

[160]  J. Lim,et al.  Therapeutic Effects of Fenofibrate on Diabetic Peripheral Neuropathy by Improving Endothelial and Neural Survival in db/db Mice , 2014, PloS one.

[161]  H. Nukada.  Ischemia and diabetic neuropathy. , 2014, Handbook of clinical neurology.

[162]  D. Andersson,et al.  Correction: Methylglyoxal Evokes Pain by Stimulating TRPA1 , 2013, PLoS ONE.

[163]  H. Kenngott,et al.  Gastric Bypass Leads to Improvement of Diabetic Neuropathy Independent of Glucose Normalization—Results of a Prospective Cohort Study (DiaSurg 1 Study) , 2013, Annals of surgery.

[164]  F. Court,et al.  Schwann cell‐derived exosomes enhance axonal regeneration in the peripheral nervous system , 2013, Glia.

[165]  D. Julius.  TRP channels and pain. , 2013, Annual review of cell and developmental biology.

[166]  F. Schifano,et al.  Ruboxistaurin for the Treatment of Diabetic Peripheral Neuropathy: A Systematic Review of Randomized Clinical Trials , 2013, Diabetes & metabolism journal.

[167]  Aiman S Saab,et al.  Neurotransmitter-Triggered Transfer of Exosomes Mediates Oligodendrocyte–Neuron Communication , 2013, PLoS biology.

[168]  I. Obrosova,et al.  Endoplasmic Reticulum Stress Plays a Key Role in the Pathogenesis of Diabetic Peripheral Neuropathy , 2013, Diabetes.

[169]  R. Fields,et al.  Gap junction communication in myelinating glia. , 2013, Biochimica et biophysica acta.

[170]  P. Wiffen.  ENHANCED GLUCOSE CONTROL FOR PREVENTING AND TREATING DIABETIC NEUROPATHY , 2012 .

[171]  B. Ransom,et al.  Schwann cell glycogen selectively supports myelinated axon function , 2012, Annals of neurology.

[172]  B. Spencer‐Dene,et al.  c-Jun in Schwann cells promotes axonal regeneration and motoneuron survival via paracrine signaling , 2012, The Journal of cell biology.

[173]  Pierre J. Magistretti,et al.  Oligodendroglia metabolically support axons and contribute to neurodegeneration , 2012, Nature.

[174]  Paul J Thornalley,et al.  Methylglyoxal modification of Nav1.8 facilitates nociceptive neuron firing and causes hyperalgesia in diabetic neuropathy , 2012, Nature Medicine.

[175]  Jens Frahm,et al.  Glycolytic oligodendrocytes maintain myelin and long-term axonal integrity , 2012, Nature.

[176]  Ralf Baron,et al.  Deconstructing the Neuropathic Pain Phenotype to Reveal Neural Mechanisms , 2012, Neuron.

[177]  H. V. Jagadish,et al.  The identification of gene expression profiles associated with progression of human diabetic neuropathy. , 2011, Brain : a journal of neurology.

[178]  A. Boulton,et al.  Prevalence and Characteristics of Painful Diabetic Neuropathy in a Large Community-Based Diabetic Population in the U.K. , 2011, Diabetes Care.

[179]  E. Feldman,et al.  Cortical neurons develop insulin resistance and blunted Akt signaling: a potential mechanism contributing to enhanced ischemic injury in diabetes. , 2011, Antioxidants & redox signaling.

[180]  S. Carr,et al.  Lipid profiling identifies a triacylglycerol signature of insulin resistance and improves diabetes prediction in humans. , 2011, The Journal of clinical investigation.

[181]  Ferdinando Giacco,et al.  Oxidative stress and diabetic complications. , 2010, Circulation research.

[182]  A. Xu,et al.  Angiotensin II type 1 receptor-dependent oxidative stress mediates endothelial dysfunction in type 2 diabetic mice. , 2010, Antioxidants & redox signaling.

[183]  R. Wanders,et al.  A general introduction to the biochemistry of mitochondrial fatty acid β-oxidation , 2010, Journal of Inherited Metabolic Disease.

[184]  N. Calcutt,et al.  Mitochondrial Respiratory Chain Dysfunction in Dorsal Root Ganglia of Streptozotocin-Induced Diabetic Rats and Its Correction by Insulin Treatment , 2010, Diabetes.

[185]  R. Schmidt,et al.  Mitochondrial stress and the pathogenesis of diabetic neuropathy , 2010, Expert review of endocrinology & metabolism.

[186]  E. Feldman,et al.  Dyslipidemia-Induced Neuropathy in Mice , 2009, Diabetes.

[187]  M. Laakso,et al.  Effect of fenofibrate on amputation events in people with type 2 diabetes mellitus (FIELD study): a prespecified analysis of a randomised controlled trial , 2009, The Lancet.

[188]  E. Feldman,et al.  Sensory neurons and schwann cells respond to oxidative stress by increasing antioxidant defense mechanisms. , 2009, Antioxidants & redox signaling.

[189]  A. Guzel,et al.  Macrophage depletion delays progression of neuropathic pain in diabetic animals , 2009, Naunyn-Schmiedeberg's Archives of Pharmacology.

[190]  D. Malide,et al.  The facilitative glucose transporter GLUT3: 20 years of distinction. , 2008, American journal of physiology. Endocrinology and metabolism.

[191]  Patrick R Hof,et al.  Functional Trade-Offs in White Matter Axonal Scaling , 2008, The Journal of Neuroscience.

[192]  R. Wada,et al.  Correction of protein kinase C activity and macrophage migration in peripheral nerve by pioglitazone, peroxisome proliferator activated‐γ‐ligand, in insulin‐deficient diabetic rats , 2007, Journal of neurochemistry.

[193]  J. Veerkamp,et al.  Fatty acid-binding proteins of nervous tissue , 2001, Journal of Molecular Neuroscience.

[194]  E. Davidson,et al.  ACE inhibitor or angiotensin II receptor antagonist attenuates diabetic neuropathy in streptozotocin-induced diabetic rats. , 2006, Diabetes.

[195]  E. Feldman,et al.  Short‐term hyperglycemia produces oxidative damage and apoptosis in neurons , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[196]  P. K. Thomas,et al.  Sural nerve pathology in diabetic patients with minimal but progressive neuropathy , 2005, Diabetologia.

[197]  E. Feldman,et al.  The role of growth factors in diabetic peripheral neuropathy , 2004, Journal of the peripheral nervous system : JPNS.

[198]  P. Williams,et al.  Perineurial cell basement membrane thickening and myelinated nerve fibre loss in diabetic and nondiabetic peripheral nerve , 2004, Journal of the Neurological Sciences.

[199]  K. Eriksson,et al.  Endoneurial capillary abnormalities presage deterioration of glucose tolerance and accompany peripheral neuropathy in man. , 2003, Diabetes.

[200]  E. Ringelstein,et al.  Macrophage Response to Peripheral Nerve Injury: The Quantitative Contribution of Resident and Hematogenous Macrophages , 2003, Laboratory Investigation.

[201]  Jean-Louis Martiel,et al.  Uptake of locally applied deoxyglucose, glucose and lactate by axons and schwann cells of rat vagus nerve , 2003, The Journal of physiology.

[202]  J. Olzmann,et al.  High glucose‐induced oxidative stress and mitochondrial dysfunction in neurons , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[203]  K. Sugimoto,et al.  Expression and localization of insulin receptor in rat dorsal root ganglion and spinal cord , 2002, Journal of the peripheral nervous system : JPNS.

[204]  S. Tesfaye,et al.  Vascular factors and metabolic interactions in the pathogenesis of diabetic neuropathy , 2001, Diabetologia.

[205]  D. Raederstorff,et al.  Prevention of nerve conduction deficit in diabetic rats by polyunsaturated fatty acids. , 2000, The American journal of clinical nutrition.

[206]  G. Gould,et al.  Glucose transporters in rat peripheral nerve: paranodal expression of GLUT1 and GLUT3. , 1996, Metabolism: clinical and experimental.

[207]  G. Raivich,et al.  MHC-positive, ramified macrophages in the normal and injured rat peripheral nervous system , 1992, Journal of neurocytology.

[208]  M. Crawford,et al.  Differential oxidation of saturated and unsaturated fatty acids in vivo in the rat , 1987, British Journal of Nutrition.